RxDoctor Payments Data

William Marrero Ortiz

Geriatric Medicine · San Juan, PRNPI 1619418027

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 108 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AstraZeneca at 24.1% of the total. Reporting peaked in 2024 at $1,445 and has fallen 66.4% since, to $486 in 2025. Among geriatric medicine clinicians in PR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,198in general payments, 2019–2025

Across 108 payments — averaging $29.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$772
  • E.r. Squibb & Sons, L.L.C.$644
  • PBG Puerto Rico LLC$440
  • GSK$153
  • Novo Nordisk$136
  • Boehringer Ingelheim$133
  • plus $920 from 12 others

What the payments were for

  • Food & beverage$3,198100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,198 in reported general payments places this provider in the 90th percentile of 76 geriatric medicine providers in Puerto Rico.

See all geriatric medicine providers in Puerto Rico

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide18$17,584
JanuviaSitagliptin Phosphate14$11,438
FarxigaDapagliflozin Propanediol11$9,590
SynthroidLevothyroxine Sodium41$3,272
Omega-3 Acid Ethyl Esters29$2,477
Estazolam32$1,742
Clonazepam132$1,380
Temazepam105$1,120
Pregabalin17$730
Gabapentin48$570
Valsartan19$560
Doxazosin Mesylate26$560
Zolpidem Tartrate46$552
Famotidine46$547
Atorvastatin Calcium55$533

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$136$17,58418 claims
AstraZenecaFarxiga$772$9,59011 claims
AbbVieSynthroid$72$3,27241 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 76 geriatric medicine providers in Puerto Rico.

Other geriatric medicine in San Juan

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →